{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T16:43:47Z","timestamp":1777481027448,"version":"3.51.4"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T00:00:00Z","timestamp":1692316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T00:00:00Z","timestamp":1692316800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100010661","name":"EC | Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["945246"],"award-info":[{"award-number":["945246"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"EC | Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["945246"],"award-info":[{"award-number":["945246"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"EC | Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["945246"],"award-info":[{"award-number":["945246"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"EC | Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["945246"],"award-info":[{"award-number":["945246"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"EC | Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["945246"],"award-info":[{"award-number":["945246"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"EC | Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["945246"],"award-info":[{"award-number":["945246"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP2007006"],"award-info":[{"award-number":["APP2007006"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP2007006"],"award-info":[{"award-number":["APP2007006"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP2007006"],"award-info":[{"award-number":["APP2007006"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP2007006"],"award-info":[{"award-number":["APP2007006"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NYU Grossman School of Medicine DigiCare4You funding subaward"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Digit. Med."],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Digital health interventions have been shown to be clinically-effective for type 2 diabetes mellitus (T2DM) and hypertension prevention and treatment. This study synthesizes and compares the cost-effectiveness of text-messaging, smartphone application, and websites by searching CINAHL, Cochrane Central, Embase, Medline and PsycInfo for full economic or cost-minimisation studies of digital health interventions in adults with or at risk of T2DM and\/or hypertension. Costs and health effects are synthesised narratively. Study quality appraisal using the Consensus on Health Economic Criteria (CHEC) list results in recommendations for future health economic evaluations of digital health interventions. Of 3056 records identified, 14 studies are included (7 studies applied text-messaging, 4 employed smartphone applications, and 5 used websites). Ten studies are cost-utility analyses: incremental cost-utility ratios (ICUR) vary from dominant to \u20ac75,233\/quality-adjusted life year (QALY), with a median of \u20ac3840\/QALY (interquartile range \u20ac16,179). One study finds no QALY difference. None of the three digital health intervention modes is associated with substantially better cost-effectiveness. Interventions are consistently cost-effective in populations with (pre)T2DM but not in populations with hypertension. Mean quality score is 63.0% (standard deviation 13.7%). Substandard application of time horizon, sensitivity analysis, and subgroup analysis next to transparency concerns (regarding competing alternatives, perspective, and costing) downgrades quality of evidence. In conclusion, smartphone application, text-messaging, and website-based interventions are cost-effective without substantial differences between the different delivery modes. Future health economic studies should increase transparency, conduct sufficient sensitivity analyses, and appraise the ICUR more critically in light of a reasoned willingness-to-pay threshold.<\/jats:p><jats:p><jats:bold>Registration:<\/jats:bold> PROSPERO (CRD42021247845).<\/jats:p>","DOI":"10.1038\/s41746-023-00876-x","type":"journal-article","created":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T07:02:31Z","timestamp":1692342151000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Cost effectiveness review of text messaging, smartphone application, and website interventions targeting T2DM or hypertension"],"prefix":"10.1038","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8732-9455","authenticated-orcid":false,"given":"Ruben","family":"Willems","sequence":"first","affiliation":[]},{"given":"Lieven","family":"Annemans","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1407-0846","authenticated-orcid":false,"given":"George","family":"Siopis","sequence":"additional","affiliation":[]},{"given":"George","family":"Moschonis","sequence":"additional","affiliation":[]},{"given":"Rajesh","family":"Vedanthan","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1774-1177","authenticated-orcid":false,"given":"Jenny","family":"Jung","sequence":"additional","affiliation":[]},{"given":"Dominika","family":"Kwasnicka","sequence":"additional","affiliation":[]},{"given":"Brian","family":"Oldenburg","sequence":"additional","affiliation":[]},{"given":"Claudia","family":"d\u2019Antonio","sequence":"additional","affiliation":[]},{"given":"Sandro","family":"Girolami","sequence":"additional","affiliation":[]},{"given":"Eirini","family":"Agapidaki","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6486-114X","authenticated-orcid":false,"given":"Yannis","family":"Manios","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9956-4970","authenticated-orcid":false,"given":"Nick","family":"Verhaeghe","sequence":"additional","affiliation":[]},{"name":"DigiCare 4You","sequence":"additional","affiliation":[]},{"given":"Natalya","family":"Usheva","sequence":"additional","affiliation":[]},{"given":"Violeta","family":"Iotova","sequence":"additional","affiliation":[]},{"given":"Andreas","family":"Triantafyllidis","sequence":"additional","affiliation":[]},{"given":"Konstantinos","family":"Votis","sequence":"additional","affiliation":[]},{"given":"Florian","family":"Toti","sequence":"additional","affiliation":[]},{"given":"Konstantinos","family":"Makrilakis","sequence":"additional","affiliation":[]},{"given":"Chiara","family":"Seghieri","sequence":"additional","affiliation":[]},{"given":"Luis","family":"Moreno","sequence":"additional","affiliation":[]},{"given":"Sabine","family":"Dupont","sequence":"additional","affiliation":[]},{"given":"Leo","family":"Lewis","sequence":"additional","affiliation":[]},{"given":"Djordje","family":"Djokic","sequence":"additional","affiliation":[]},{"given":"Helen","family":"Skouteris","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2023,8,18]]},"reference":[{"key":"876_CR1","unstructured":"IDF. IDF Atlas 10th edn (International Diabetes Federation, 2021)."},{"key":"876_CR2","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1007\/s00125-013-2902-4","volume":"56","author":"DH Morris","year":"2013","unstructured":"Morris, D. H. et al. Progression rates from HbA1c 6.0-6.4% and other prediabetes definitions to type 2 diabetes: a meta-analysis. Diabetologia 56, 1489\u20131493 (2013).","journal-title":"Diabetologia"},{"key":"876_CR3","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1161\/01.HYP.37.4.1053","volume":"37","author":"JR Sowers","year":"2001","unstructured":"Sowers, J. R., Epstein, M. & Frohlich, E. D. Diabetes, hypertension, and cardiovascular disease: an update. Hypertension (Dallas, Tex. : 1979) 37, 1053\u20131059 (2001).","journal-title":"Hypertension (Dallas, Tex. : 1979)"},{"key":"876_CR4","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41581-019-0244-2","volume":"16","author":"KT Mills","year":"2020","unstructured":"Mills, K. T., Stefanescu, A. & He, J. The global epidemiology of hypertension. Nat. Rev. Nephrol. 16, 223\u2013237 (2020).","journal-title":"Nat. Rev. Nephrol."},{"key":"876_CR5","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/nrcardio.2015.17","volume":"12","author":"BM Egan","year":"2015","unstructured":"Egan, B. M. & Stevens-Fabry, S. Prehypertension\u2013prevalence, health risks, and management strategies. Nat. Rev. Cardiol. 12, 289\u2013300 (2015).","journal-title":"Nat. Rev. Cardiol."},{"key":"876_CR6","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1093\/eurheartj\/ehw106","volume":"37","author":"MF Piepoli","year":"2016","unstructured":"Piepoli, M. F. et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: the sixth joint task force of the European society of cardiology and other societies on cardiovascular disease Prevention in clinical practice (constituted by representatives of 10 societies and by invited experts) developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur. Heart J. 37, 2315\u20132381 (2016).","journal-title":"Eur. Heart J."},{"key":"876_CR7","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ejim.2015.11.016","volume":"27","author":"XL Huang","year":"2016","unstructured":"Huang, X. L. et al. Efficacy of lifestyle interventions in patients with type 2 diabetes: a systematic review and meta-analysis. Eur. J. Intern. Med. 27, 37\u201347 (2016).","journal-title":"Eur. J. Intern. Med."},{"key":"876_CR8","doi-asserted-by":"crossref","first-page":"2159890","DOI":"10.1155\/2016\/2159890","volume":"2016","author":"K Alouki","year":"2016","unstructured":"Alouki, K., Delisle, H., Berm\u00fadez-Tamayo, C. & Johri, M. Lifestyle interventions to prevent type 2 diabetes: a systematic review of economic evaluation studies. J. Diabetes Res. 2016, 2159890 (2016).","journal-title":"J. Diabetes Res."},{"key":"876_CR9","doi-asserted-by":"crossref","first-page":"e017184","DOI":"10.1136\/bmjopen-2017-017184","volume":"7","author":"S Roberts","year":"2017","unstructured":"Roberts, S. et al. Preventing type 2 diabetes: systematic review of studies of cost-effectiveness of lifestyle programmes and metformin, with and without screening, for pre-diabetes. BMJ Open 7, e017184 (2017).","journal-title":"BMJ Open"},{"key":"876_CR10","doi-asserted-by":"crossref","first-page":"452","DOI":"10.7326\/M15-0469","volume":"163","author":"R Li","year":"2015","unstructured":"Li, R. et al. Economic evaluation of combined diet and physical activity promotion programs to prevent type 2 diabetes among persons at increased risk: a systematic review for the community preventive services task force. Ann. Intern. Med. 163, 452\u2013460 (2015).","journal-title":"Ann. Intern. Med."},{"key":"876_CR11","doi-asserted-by":"crossref","first-page":"106722","DOI":"10.1016\/j.ypmed.2021.106722","volume":"153","author":"R Willems","year":"2021","unstructured":"Willems, R. et al. Cost-effectiveness analysis of a school- and community-based intervention to promote a healthy lifestyle and prevent type 2 diabetes in vulnerable families across Europe: the Feel4Diabetes-study. Prev. Med. 153, 106722 (2021).","journal-title":"Prev. Med."},{"key":"876_CR12","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1001\/jama.2013.281078","volume":"310","author":"SR Steinhubl","year":"2013","unstructured":"Steinhubl, S. R., Muse, E. D. & Topol, E. J. Can mobile health technologies transform health care? JAMA 310, 2395\u20132396 (2013).","journal-title":"JAMA"},{"key":"876_CR13","unstructured":"Bankmycell.com. How Many Smartphones are in the World? https:\/\/www.bankmycell.com\/blog\/how-many-phones-are-in-the-world (2022)."},{"key":"876_CR14","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1093\/jamia\/ocaa029","volume":"27","author":"W Choi","year":"2020","unstructured":"Choi, W., Wang, S., Lee, Y., Oh, H. & Zheng, Z. A systematic review of mobile health technologies to support self-management of concurrent diabetes and hypertension. J. Am. Med Inf. Assoc. 27, 939\u2013945 (2020).","journal-title":"J. Am. Med Inf. Assoc."},{"key":"876_CR15","first-page":"e312","volume":"93","author":"YK Zhai","year":"2014","unstructured":"Zhai, Y. K., Zhu, W. J., Cai, Y. L., Sun, D. X. & Zhao, J. Clinical- and cost-effectiveness of telemedicine in type 2 diabetes mellitus: a systematic review and meta-analysis. Med. (U. S.) 93, e312 (2014).","journal-title":"Med. (U. S.)"},{"key":"876_CR16","doi-asserted-by":"crossref","first-page":"e15400","DOI":"10.2196\/15400","volume":"8","author":"Y Wang","year":"2020","unstructured":"Wang, Y. et al. Effectiveness of mobile health interventions on diabetes and obesity treatment and management: systematic review of systematic reviews. JMIR Mhealth Uhealth 8, e15400 (2020).","journal-title":"JMIR Mhealth Uhealth"},{"key":"876_CR17","doi-asserted-by":"crossref","first-page":"e17776","DOI":"10.2196\/17776","volume":"8","author":"R Li","year":"2020","unstructured":"Li, R., Liang, N., Bu, F. & Hesketh, T. The effectiveness of self-management of hypertension in adults using mobile health: systematic review and meta-analysis. JMIR Mhealth Uhealth 8, e17776 (2020).","journal-title":"JMIR Mhealth Uhealth"},{"key":"876_CR18","doi-asserted-by":"crossref","DOI":"10.1038\/s41746-021-00486-5","volume":"4","author":"EC Khoong","year":"2021","unstructured":"Khoong, E. C. et al. Mobile health strategies for blood pressure self-management in urban populations with digital barriers: systematic review and meta-analyses. NPJ Digit. Med. 4, 114 (2021).","journal-title":"NPJ Digit. Med."},{"key":"876_CR19","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.1016\/S2589-7500(22)00233-3","volume":"5","author":"G Moschonis","year":"2023","unstructured":"Moschonis, G. et al. Effectiveness, reach, uptake, and feasibility of digital health interventions for adults with type 2 diabetes: A systematic literature review and meta-analysis of randomised controlled trials. Lancet Digit. Health 5, e125\u2013e143 (2023).","journal-title":"Lancet Digit. Health"},{"key":"876_CR20","doi-asserted-by":"crossref","first-page":"e144","DOI":"10.1016\/S2589-7500(23)00002-X","volume":"5","author":"G Siopis","year":"2023","unstructured":"Siopis, G. et al. Effectiveness, reach, uptake, and feasibility of digital health interventions for adults with hypertension: A systematic literature review and meta-analysis of randomised controlled trials. Lancet Digit. Health 5, e144\u2013e159 (2023).","journal-title":"Lancet Digit. Health"},{"key":"876_CR21","unstructured":"WHO. mHealth: new horizons for health through mobile technologies: based on the second global survey on eHealth. in Global Observatory for eHealth, Vol. 3 (World Health Organization, Geneva, 2011)."},{"key":"876_CR22","doi-asserted-by":"crossref","first-page":"e0170581","DOI":"10.1371\/journal.pone.0170581","volume":"12","author":"SJ Iribarren","year":"2017","unstructured":"Iribarren, S. J., Cato, K., Falzon, L. & Stone, P. W. What is the economic evidence for mHealth? A systematic review of economic evaluations of mHealth solutions. PloS One 12, e0170581 (2017).","journal-title":"PloS One"},{"key":"876_CR23","doi-asserted-by":"crossref","first-page":"108084","DOI":"10.1016\/j.diabres.2020.108084","volume":"162","author":"G Rinaldi","year":"2020","unstructured":"Rinaldi, G., Hijazi, A. & Haghparast-Bidgoli, H. Cost and cost-effectiveness of mHealth interventions for the prevention and control of type 2 diabetes mellitus: a systematic review. Diabetes Res. Clin. Pract. 162, 108084 (2020).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"876_CR24","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s41669-022-00377-9","volume":"7","author":"T Morris","year":"2022","unstructured":"Morris, T., Aspinal, F., Ledger, J., Li, K. & Gomes, M. The impact of digital health interventions for the management of type 2 diabetes on health and social care utilisation and costs: a systematic review. Pharmacoecon Open 7, 163\u2013173 (2022).","journal-title":"Pharmacoecon Open"},{"key":"876_CR25","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1080\/14737167.2016.1246961","volume":"16","author":"B Wijnen","year":"2016","unstructured":"Wijnen, B. et al. How to prepare a systematic review of economic evaluations for informing evidence-based healthcare decisions: data extraction, risk of bias, and transferability (part 3\/3). Expert Rev. Pharmacoecon. Outcomes Res. 16, 723\u2013732 (2016).","journal-title":"Expert Rev. Pharmacoecon. Outcomes Res."},{"key":"876_CR26","doi-asserted-by":"crossref","first-page":"e0163627","DOI":"10.1371\/journal.pone.0163627","volume":"11","author":"F Chen","year":"2016","unstructured":"Chen, F. et al. Clinical and economic impact of a digital, remotely-delivered intensive behavioral counseling program on medicare beneficiariesat risk for diabetes and cardiovascular disease. PLoS One 11, e0163627 (2016).","journal-title":"PLoS One"},{"key":"876_CR27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2196\/jmir.8338","volume":"20","author":"J Li","year":"2018","unstructured":"Li, J. et al. Cost-effectiveness of facilitated access to a self-management website, compared to usual Care, for patients with type 2 diabetes (HeLP-diabetes): randomized controlled trial. J. Med. Internet Res. 20, 1\u201315 (2018).","journal-title":"J. Med. Internet Res."},{"key":"876_CR28","doi-asserted-by":"crossref","first-page":"m4858","DOI":"10.1136\/bmj.m4858","volume":"372","author":"RJ McManus","year":"2021","unstructured":"McManus, R. J. et al. Home and Online Management and Evaluation of Blood Pressure (HOME BP) using a digital intervention in poorly controlled hypertension: randomised controlled trial. BMJ 372, m4858 (2021).","journal-title":"BMJ"},{"key":"876_CR29","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1177\/19322968211069172","volume":"17","author":"SG Cunningham","year":"2022","unstructured":"Cunningham, S. G. et al. Cost-utility of an online education platform and diabetes personal health record: analysis over ten years. J. Diabetes Sci. Technol. 17, 715\u2013726 (2022).","journal-title":"J. Diabetes Sci. Technol."},{"key":"876_CR30","doi-asserted-by":"crossref","first-page":"915847","DOI":"10.3389\/fnut.2022.915847","volume":"9","author":"SM Derakhshandeh-Rishehri","year":"2022","unstructured":"Derakhshandeh-Rishehri, S. M., Keshavarz, K., Ghodsi, D., Pishdad, G. & Faghih, S. Cost-effectiveness analysis of group vs. Weblog Telecommunication (Web Tel) nutrition education program on glycemic indices in patients with non-insulin dependent diabetes mellitus type 2: a randomized controlled trial. Front. Nutr. 9, 915847 (2022).","journal-title":"Front. Nutr."},{"key":"876_CR31","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.jval.2018.06.003","volume":"21","author":"F Augustovski","year":"2018","unstructured":"Augustovski, F. et al. Cost-effectiveness of a comprehensive approach for hypertension control in low-income settings in Argentina: trial-based analysis of the hypertension control program in Argentina. Value Health 21, 1357\u20131364 (2018).","journal-title":"Value Health"},{"key":"876_CR32","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.vhri.2018.12.006","volume":"20","author":"T Gilmer","year":"2019","unstructured":"Gilmer, T., Burgos, J. L., Anzaldo-Campos, M. C. & Vargas-Ojeda, A. Cost-effectiveness of a technology-enhanced diabetes care management program in Mexico. Value Health Reg. Issues 20, 41\u201346 (2019).","journal-title":"Value Health Reg. Issues"},{"key":"876_CR33","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.hlpt.2019.12.003","volume":"9","author":"SMS Islam","year":"2020","unstructured":"Islam, S. M. S. et al. Cost-effectiveness of a mobile-phone text messaging intervention on type 2 diabetes\u2014a randomized-controlled trial. Health Policy Technol. 9, 79\u201385 (2020).","journal-title":"Health Policy Technol."},{"key":"876_CR34","first-page":"1219581","volume":"2016","author":"CK Wong","year":"2016","unstructured":"Wong, C. K. et al. Cost-effectiveness of a short message service intervention to prevent type 2 diabetes from impaired glucose tolerance. J. Diabetes Res. 2016, 1219581 (2016).","journal-title":"J. Diabetes Res."},{"key":"876_CR35","doi-asserted-by":"publisher","unstructured":"Faleh AlMutairi, M. et al. Cost-effectiveness of telemedicine care for patients with uncontrolled type 2 diabetes mellitus during the COVID-19 pandemic in Saudi Arabia. Ther. Adv. Chronic Dis. https:\/\/doi.org\/10.1177\/204062232110425 (2021).","DOI":"10.1177\/204062232110425"},{"key":"876_CR36","doi-asserted-by":"crossref","first-page":"e2122559","DOI":"10.1001\/jamanetworkopen.2021.22559","volume":"4","author":"Y Zhang","year":"2021","unstructured":"Zhang, Y. et al. Cost-effectiveness of a multicomponent Iintervention for hypertension control in low-income settings in Argentina. JAMA Netw. Open 4, e2122559 (2021).","journal-title":"JAMA Netw. Open"},{"key":"876_CR37","doi-asserted-by":"crossref","first-page":"e16053","DOI":"10.2196\/16053","volume":"22","author":"S Tsuji","year":"2020","unstructured":"Tsuji, S. et al. Cost-effectiveness of a continuous glucose monitoring mobile app for patients with type 2 diabetes mellitus: analysis simulation. J. Med. Internet Res. 22, e16053 (2020).","journal-title":"J. Med. Internet Res."},{"key":"876_CR38","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s11739-019-02146-9","volume":"15","author":"X Zhang","year":"2020","unstructured":"Zhang, X. et al. Cost-effectiveness analysis of different hypertension management strategies in a community setting. Intern. Emerg. Med. 15, 241\u2013250 (2020).","journal-title":"Intern. Emerg. Med."},{"key":"876_CR39","first-page":"8827629","volume":"2021","author":"J Li","year":"2021","unstructured":"Li, J., Sun, L., Hou, Y. & Chen, L. Cost-effectiveness analysis of a mobile-based intervention for patients with type 2 diabetes mellitus. Int. J. Endocrinol. 2021, 8827629 (2021).","journal-title":"Int. J. Endocrinol."},{"key":"876_CR40","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0140-6736(21)01916-4","volume":"398","author":"R Jackson","year":"2021","unstructured":"Jackson, R. & Wells, S. Time to remove hypertension from our vocabulary? Lancet (Lond., Engl.) 398, 1023\u20131025 (2021).","journal-title":"Lancet (Lond., Engl.)"},{"key":"876_CR41","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0140-6736(19)31964-6","volume":"394","author":"L The","year":"2019","unstructured":"The, L. Is the concept of hypertension as a disease unhelpful? Lancet (Lond., Engl.) 394, 611 (2019).","journal-title":"Lancet (Lond., Engl.)"},{"key":"876_CR42","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1146\/annurev-publhealth-031914-122848","volume":"36","author":"B Oldenburg","year":"2015","unstructured":"Oldenburg, B., Taylor, C. B., O'Neil, A., Cocker, F. & Cameron, L. D. Using new technologies to improve the prevention and management of chronic conditions in populations. Annu Rev. Public Health 36, 483\u2013505 (2015).","journal-title":"Annu Rev. Public Health"},{"key":"876_CR43","doi-asserted-by":"crossref","first-page":"e12505","DOI":"10.2196\/12505","volume":"21","author":"V P\u00e9rez-Jover","year":"2019","unstructured":"P\u00e9rez-Jover, V., Sala-Gonz\u00e1lez, M., Guilabert, M. & Mira, J. J. Mobile apps for increasing treatment adherence: systematic review. J. Med. Internet Res. 21, e12505 (2019).","journal-title":"J. Med. Internet Res."},{"key":"876_CR44","doi-asserted-by":"crossref","first-page":"e20283","DOI":"10.2196\/20283","volume":"22","author":"G Meyerowitz-Katz","year":"2020","unstructured":"Meyerowitz-Katz, G. et al. Rates of attrition and dropout in app-based interventions for chronic disease: systematic review and meta-analysis. J. Med. Internet Res. 22, e20283 (2020).","journal-title":"J. Med. Internet Res."},{"key":"876_CR45","doi-asserted-by":"crossref","first-page":"112786","DOI":"10.1016\/j.physbeh.2019.112786","volume":"215","author":"G Jabardo-Camprub\u00ed","year":"2020","unstructured":"Jabardo-Camprub\u00ed, G., Donat-Roca, R., Sitj\u00e0-Rabert, M., Mil\u00e0-Villarroel, R. & Bort-Roig, J. Drop-out ratio between moderate to high-intensity physical exercise treatment by patients with, or at risk of, type 2 diabetes mellitus: a systematic review and meta-analysis. Physiol. Behav. 215, 112786 (2020).","journal-title":"Physiol. Behav."},{"key":"876_CR46","doi-asserted-by":"crossref","unstructured":"Eyles, H. et al. Co-design of mHealth delivered interventions: a systematic review to assess key methods and processes. Curr. Nutr. Rep. 5, 160\u2013167 (2016).","DOI":"10.1007\/s13668-016-0165-7"},{"key":"876_CR47","unstructured":"WHO. Commission on Macroeconomics and Health. Macroeconomics and Health: Investing in Health for Economic Development (World Health Organization, Geneva, 2001)."},{"key":"876_CR48","doi-asserted-by":"crossref","first-page":"925","DOI":"10.2471\/BLT.15.164418","volume":"94","author":"MY Bertram","year":"2016","unstructured":"Bertram, M. Y. et al. Cost-effectiveness thresholds: pros and cons. Bull. World Health Organ. 94, 925\u2013930 (2016).","journal-title":"Bull. World Health Organ."},{"key":"876_CR49","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.jval.2016.02.017","volume":"19","author":"B Woods","year":"2016","unstructured":"Woods, B., Revill, P., Sculpher, M. & Claxton, K. Country-level cost-effectiveness thresholds: initial estimates and the need for further research. Value Health 19, 929\u2013935 (2016).","journal-title":"Value Health"},{"key":"876_CR50","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1001\/jama.2021.11165","volume":"326","author":"JM Lawrence","year":"2021","unstructured":"Lawrence, J. M. et al. Trends in prevalence of type 1 and type 2 diabetes in children and adolescents in the US, 2001\u20132017. JAMA 326, 717\u2013727 (2021).","journal-title":"JAMA"},{"key":"876_CR51","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1001\/jamapediatrics.2019.3310","volume":"173","author":"P Song","year":"2019","unstructured":"Song, P. et al. Global prevalence of hypertension in children: a systematic review and meta-analysis. JAMA Pediatr. 173, 1154\u20131163 (2019).","journal-title":"JAMA Pediatr."},{"key":"876_CR52","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/ajh\/hpz181","volume":"33","author":"SA Abariga","year":"2020","unstructured":"Abariga, S. A., Khachan, H. & Al Kibria, G. M. Prevalence and determinants of hypertension in India based on the 2017 ACC\/AHA guideline: evidence from the India National Family Health Survey. Am. J. Hypertens. 33, 252\u2013260 (2020).","journal-title":"Am. J. Hypertens."},{"key":"876_CR53","doi-asserted-by":"crossref","first-page":"e1004053","DOI":"10.1371\/journal.pmed.1004053","volume":"19","author":"F Bragg","year":"2022","unstructured":"Bragg, F. & Chen, Z. Estimating lifetime risk of diabetes in the Chinese population. PLoS Med. 19, e1004053 (2022).","journal-title":"PLoS Med."},{"key":"876_CR54","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.jval.2021.01.002","volume":"24","author":"OL Mandrik","year":"2021","unstructured":"Mandrik, O. L. et al. Critical appraisal of systematic reviews with costs and cost-effectiveness outcomes: an ISPOR good practices task force report. Value Health 24, 463\u2013472 (2021).","journal-title":"Value Health"},{"key":"876_CR55","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jval.2015.02.001","volume":"18","author":"SD Ramsey","year":"2015","unstructured":"Ramsey, S. D. et al. Cost-effectiveness analysis alongside clinical trials II-An ISPOR good research practices task force report. Value Health 18, 161\u2013172 (2015).","journal-title":"Value Health"},{"key":"876_CR56","doi-asserted-by":"crossref","unstructured":"Page, M. J. et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372, n71 (2021).","DOI":"10.1136\/bmj.n71"},{"key":"876_CR57","unstructured":"Werbrouck, A. Disease prevention and health promotion in Flanders : health economic evidence to support healthcare decision making. (Ghent University and University of Leuven, 2021)."},{"key":"876_CR58","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1007\/s40273-013-0103-0","volume":"31","author":"M Neyt","year":"2013","unstructured":"Neyt, M. & Chalon, P. X. Search MEDLINE for economic evaluations: tips to translate an OVID strategy into a PubMed one. PharmacoEconomics 31, 1087\u20131090 (2013).","journal-title":"PharmacoEconomics"},{"key":"876_CR59","unstructured":"University of York. Search Strategies (University of York, 2018)."},{"key":"876_CR60","doi-asserted-by":"crossref","unstructured":"Ouzzani, M., Hammady, H., Fedorowicz, Z. & Elmagarmid, A. Rayyan\u2014a web and mobile app for systematic reviews. Syst. Rev. 5, 210 (2016).","DOI":"10.1186\/s13643-016-0384-4"},{"key":"876_CR61","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1080\/14737167.2016.1246960","volume":"16","author":"GA van Mastrigt","year":"2016","unstructured":"van Mastrigt, G. A. et al. How to prepare a systematic review of economic evaluations for informing evidence-based healthcare decisions: a five-step approach (part 1\/3). Expert Rev. Pharmacoecon. Outcomes Res. 16, 689\u2013704 (2016).","journal-title":"Expert Rev. Pharmacoecon. Outcomes Res."},{"key":"876_CR62","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1017\/S0266462305050324","volume":"21","author":"S Evers","year":"2005","unstructured":"Evers, S., Goossens, M., de Vet, H., van Tulder, M. & Ament, A. Criteria list for assessment of methodological quality of economic evaluations: consensus on Health Economic Criteria. Int. J. Technol. Assess. Health Care 21, 240\u2013245 (2005).","journal-title":"Int. J. Technol. Assess. Health Care"}],"container-title":["npj Digital Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41746-023-00876-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-023-00876-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-023-00876-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T21:28:06Z","timestamp":1700602086000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41746-023-00876-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,18]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["876"],"URL":"https:\/\/doi.org\/10.1038\/s41746-023-00876-x","relation":{},"ISSN":["2398-6352"],"issn-type":[{"value":"2398-6352","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,18]]},"assertion":[{"value":"27 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"L.A. received consulting fees from Mundipharma for advice on cost-effectiveness of SGLT2 inhibitors for the management of type 2 diabetes; honoraria from Boehringer Ingelheim and Mundipharma for lectures on health economic aspects of diabetes; is a member of the board of the AstraZeneca Foundation. C.d.A. and S.G. are employees of the company Meteda, manufacturer of MetaClinic, DiaWatch METEDA, MetaDieta and MyDiet. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"150"}}